Cite
HARVARD Citation
Shi, Z. et al. (2021). Identification of biomarkers complementary to homologous recombination deficiency for improving the clinical outcome of ovarian serous cystadenocarcinoma. Clinical and translational medicine. 11 (5), p. n/a. [Online].